Business
Hikma announces injectable licensing agreement
Hikma announces injectable licensing agreement.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n \nRNS Number : 5349I Hikma Pharmaceuticals Plc 27 November 2018 \n\nLondon, 27 November 2018 - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody's / BB+ S&P, both stable) today announced a five-year licensing and supply agreement with Hansoh Pharmaceutical Group Co., Ltd. (Hansoh), one of the few research and development-driven Chinese pharmaceutical companies with leading franchises in multiple large and fast-growing therapeutic areas. \nThe agreement provides Hikma with exclusive rights to market a suite of Hansoh's injectable oncology medicines within the US for the next five years. Hansoh expects to file these products for approval with the FDA within the next 12 months. \n\"Our partnership with Hansoh will expand Hikma's growing US portfolio of vital injectable oncology medicines and strengthens our ability to serve the growing needs of US hospitals, physicians and patients,\" said Daniel Motto, Hikma's Executive Vice President of Commercial and Business Development. \"We look forward to building relationships with Hansoh and other potential partners whose pharmaceutical products can benefit from our strong commercial relationships and our well-established sales and marketing infrastructure.\"\n\"Today one out of every six generic injectable products used in US hospitals is a Hikma product, and we plan to continue adding specialised products like these to our growing portfolio of essential medicines,\" said Riad Mechlaoui, Hikma's President of Injectables. \n-- ENDS -\n \nEnquiries\nHikma Pharmaceuticals PLC\n\n\n\nSusan Ringdal\nEVP, Strategic Planning and Global Affairs\n\n\n+44 (0)20 7399 2760/ +44 7776 477050\[email protected]\n \n\n\n\n\nSteven Weiss\nSenior Director, Communications and Public Affairs \n\n\n+1 732 720 2830/ +1 732 788 8279\[email protected]\n\n\n\n \n \nFTI Consulting \n\n\n\nBen Atwell/Brett Pollard\n\n\n+44 (0)20 3727 1000\n\n\n\n \nAbout Hikma\nHikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. We're a global company with a local presence across the United States (US), the Middle East and North Afri...